About
David Hallal is a biotech executive best known for leading Alexion, co-founding ElevateBio, and serving as chairman and CEO or executive chairman across several cell and gene therapy companies. As of April 27, 2025, he is Chief Executive Officer and Chairman of Scholar Rock. He also serves as Executive Chairman of ElevateBio and AlloVir, chairs iTeos Therapeutics, and sits on the board of Seer Biosciences.
Areas of interest
biotechrare diseasecell therapygene therapygenetic medicinesdrug developmentbiomanufacturingoncology